Shang-mian Yie

Title: Innovations of Shang-mian Yie in HLA-G Detection

Introduction

Shang-mian Yie is an accomplished inventor based in North York, Canada. She has made significant contributions to the field of medical diagnostics, particularly in the detection of HLA-G. Her innovative work has the potential to enhance embryo selection processes in in vitro fertilization.

Latest Patents

Shang-mian Yie holds a patent for the "Detection of HLA-G." This invention relates to the detection of HLA-G through antibodies that target both soluble and membrane-bound forms of the protein. Notable antibodies disclosed in her patent include 2C/C8, 3C/G4, and 4H84. The antibodies 2C/C8 and 4H84 bind to the same region of HLA-G, which is distinct from the region targeted by 3C/G4. The methods of detection and diagnosis outlined in her patent include kits designed for clinical settings, featuring a miniaturized assay. Furthermore, her invention provides a method for selecting embryos for in vitro fertilization. The sandwich ELISA test described in her patent utilizes two antibodies that bind to different regions of HLA-G, demonstrating over 1000 times greater selectivity for HLA-G compared to other antigens such as HLA-A, HLA-B, HLA-C, or mixed WBC preparations.

Career Highlights

Shang-mian Yie's career is marked by her dedication to advancing medical technology. Her innovative approach to HLA-G detection has positioned her as a key figure in the field of reproductive medicine.

Collaborations

Shang-mian Yie has collaborated with Clifford L Librach, a notable figure in the medical community. Their partnership has contributed to the development of groundbreaking diagnostic methods.

Conclusion

Shang-mian Yie's work in the detection of HLA-G represents a significant advancement in medical diagnostics. Her innovative methods and collaborations continue to pave the way for improvements in reproductive health.